Last reviewed · How we verify
Klonopin
At a glance
| Generic name | Klonopin |
|---|---|
| Also known as | Clonazepam tablets |
| Sponsor | Par Pharmaceutical, Inc. |
| Target | GABA-A receptor alpha-1/beta-2/gamma-2, GABA-A receptor; anion channel, GABA-A receptor; anion channel |
| Modality | Small molecule |
| Therapeutic area | Neuroscience |
| Phase | FDA-approved |
Approved indications
- Absence seizure
- Atonic seizure
- Lennox-Gastaut syndrome
- Myoclonic seizure
- Panic disorder
Common side effects
- Drowsiness
- Ataxia
- Behavior problems
- Nausea
- Constipation
- Diarrhea
- Dry mouth
- Anorexia
- Increased appetite
- Headache
- Tremor
- Vertigo
Serious adverse events
- Respiratory depression
- Coma
- Psychosis
- Hallucinations
- Leukopenia
- Thrombocytopenia
- Hepatomegaly
- Hemiparesis
- Shortness of breath
- Anemia
Key clinical trials
- Management of Catatonic Features in Adolescents With Profound Autism (NA)
- Efficacy of Clonidine in Reducing Craving in Inpatients With Cocaine and Crack Use Disorder (PHASE4)
- Τhe Combination of Pharmacotherapy With RECOVERYTRSGR and RECOVERYTRSBDGR. (PHASE4)
- Study of Antiepileptic Drug in Generalised Convulsive Status Epilepticus (PHASE3)
- Effect of Treatments on Pain and Quality of Life in Individual With Burning Mouth Syndrome (PHASE4)
- New Combination of Chemoimmunotherapy for Systemic B-cell Lymphoma With Central Nervous System Involvement (PHASE2)
- Bioequivalence Study of Clonazepam 2 Mg Tablets (PHASE4)
- Enhancing Mobility and Mental Health in Dementia Patients (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |